Evaluate the Safety and Efficacy of HG102 as Compared to Botox® in Subject With Moderate to Severe Glabellar Lines
Clinical trial NCT05801146 · UNKNOWN
Trial details
- NCT number
- NCT05801146
- Sponsor
- Hugel
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-04
- Primary completion
- 2025-03-01
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.